Eloxx Pharmaceuticals Inc
F:3970

Watchlist Manager
Eloxx Pharmaceuticals Inc Logo
Eloxx Pharmaceuticals Inc
F:3970
Watchlist
Price: 3.195 EUR Market Closed
Market Cap: 8.8m EUR

Intrinsic Value

There is not enough data to reliably calculate the intrinsic value of Eloxx Pharmaceuticals Inc.

The Intrinsic Value is calculated as the average of DCF and Relative values:

Intrinsic Value
Not Available
Base Case Scenario
Compare Eloxx Pharmaceuticals Inc to

Fundamental Analysis

Eloxx Pharmaceuticals Inc
F:3970
US
Pharmaceuticals
Market Cap
8.8m EUR
IPO
Nov 23, 2012
US
Pharmaceuticals
Market Cap
8.8m EUR
IPO
Nov 23, 2012
Price
€
$
Company Overview
Loading...
Economic Moat
Loading...
Earnings Call
Loading...
Contacts
Loading...
How do you feel about Eloxx Pharmaceuticals Inc?
Bearish
Neutral
Bullish
Financials
Annual
Quarterly
TTM
Annual
Quarterly
TTM

Balance Sheet Decomposition
Eloxx Pharmaceuticals Inc

Current Assets 5.6m
Cash & Short-Term Investments 4.8m
Other Current Assets 854k
Non-Current Assets 413k
PP&E 413k
Current Liabilities 23.5m
Accounts Payable 3.1m
Accrued Liabilities 2.8m
Other Current Liabilities 17.6m
Non-Current Liabilities 2.6m
Long-Term Debt 2.6m
Other Non-Current Liabilities 3k
Efficiency

Free Cash Flow Analysis
Eloxx Pharmaceuticals Inc

Last Value
3-Years Average
FCF Margin
Conversion Rate

Earnings Waterfall
Eloxx Pharmaceuticals Inc

Revenue
0 USD
Operating Expenses
-19.3m USD
Operating Income
-19.3m USD
Other Expenses
-1.2m USD
Net Income
-20.5m USD
Fundamental Scores

Profitability Score
Profitability Due Diligence

Eloxx Pharmaceuticals Inc's profitability score is 49/100. The higher the profitability score, the more profitable the company is.

49/100
Profitability
Score

Eloxx Pharmaceuticals Inc's profitability score is 49/100. The higher the profitability score, the more profitable the company is.

Solvency Score
Solvency Due Diligence

Eloxx Pharmaceuticals Inc's solvency score is 26/100. The higher the solvency score, the more solvent the company is.

Low D/E
Negative Net Debt
Short-Term Solvency
Long-Term Solvency
26/100
Solvency
Score

Eloxx Pharmaceuticals Inc's solvency score is 26/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

Price Targets Summary
Eloxx Pharmaceuticals Inc

There are no price targets for Eloxx Pharmaceuticals Inc.
Lowest
Price Target
Not Available
Average
Price Target
Not Available
Highest
Price Target
Not Available
View Analyst Estimates
View Analyst Estimates

Dividends

Eloxx Pharmaceuticals Inc
does not pay dividends
Shareholder Yield

Current shareholder yield for Eloxx Pharmaceuticals Inc is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
No dividends
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

Competitive Landscape

Company Market Cap Intrinsic Valuation Profitability Solvency Price Change
1Y 3Y 5Y